Inscrição YC de Cofactor Genomics
Cofactor Genomics passou pela Y Combinator no batch Summer 2015 como uma empresa Healthcare. Abaixo: o que a empresa faz, quem a fundou e sua inscrição para a YC, reconstruída pergunta por pergunta no formulário real da YC.
- Batch YC
- Summer 2015
- Indústria
- HealthcareDiagnostics
- Tamanho da equipe
- 13
- Status
- Active
- Lançada
- 2015
Fundadores
Dave MessinaFounder/COO
Jarret GlasscockFounder/CTO
O que Cofactor Genomics faz
Cofactor uses RNA and Predictive Immune Modeling to build better biomarkers and improve patient outcomes. Led by Jarret Glasscock and a group of expert human genome scientists,Cofactor has built a new category of diagnostic technology powered by unique and powerful RNA data models built on terabytes of data. The team recently had their technology validation peer-reviewed by the organizations that set standards for diagnostic technology (CAP, AMP) and is publishing in the Journal of Molecular Diagnostics. In addition, the team made news when Cancer Physicians who sit on the committee for patient treatment guidelines (NCCN) presented a clinical study using Cofactor’s technology showing superiority in predicting the patients who will respond to immunotherapy. This initial application is an acute problem recognized widely in the rapidly developing immunotherapy industry and represents north of a billion dollar TAM. After a number of recent key milestones, the team is taking the technology more broadly to 50% of cancers diagnosed in the US. Current investors include Menlo Ventures, DCVC, and Ascension Ventures (this last investor representing the funding arm for 13 National U.S. Healthcare Systems).
Inscrição YC de Cofactor Genomics, reconstruída
Inscrição Y Combinator
Cofactor Genomics, lote Summer 2015. As verdadeiras perguntas do formulário, respondidas com dados públicos.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Cofactor Genomics
Cofactor closes the precision medicine gap with predictive diagnostics
We build diagnostic tests using RNA sequencing and predictive immune modeling to create biomarkers that better predict patient responses, mainly for cancer immunotherapy. Our product helps doctors select which patients will respond to specific treatments, improving outcomes where current diagnostics fall short.
We live and work in St. Louis, Missouri, and the company remains based there.
St. Louis grounds us with access to strong genomics talent and a supportive healthcare ecosystem, including relationships with national healthcare systems. We don't see a need to relocate right now.
21 respostas a mais na inscrição completa
Founders, Progress, Idea, Equity, Curious, Batch Preference estão na versão completa. Crie uma conta gratuita para abri-la no YC Insights, ao lado de todos os outros batches da YC.
Perguntas Frequentes
Esta é a inscrição real da YC de Cofactor Genomics?
Não. A Y Combinator mantém as inscrições submetidas em privado. Esta é uma reconstrução: as perguntas reais do formulário da YC, respondidas a partir dos dados públicos de Cofactor Genomics (notas de lançamento, históricos de fundadores, descrição do produto). Mostra como uma empresa como Cofactor Genomics se apresentaria à YC, não o texto que eles submeteram.
Em qual batch da YC Cofactor Genomics esteve?
Cofactor Genomics fez parte do batch Summer 2015 da Y Combinator.
Quem fundou o Cofactor Genomics?
O Cofactor Genomics foi fundado por Dave Messina, Jarret Glasscock.
O que o Cofactor Genomics faz?
Cofactor closes the precision medicine gap with predictive diagnostics
Como eu leio o application completo reconstruído?
Crie uma conta gratuita no Round Funded. A versão completa de 26 respostas do application do Cofactor Genomics, e de todos os outros lotes do YC, está no YC Insights.
Mais startups YC como Cofactor Genomics
